Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$140.00$140.00derivedno prior Q4 2012 on file Net Income-$2.99K-$2.99KderivedN/M vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$140−61.1% Operating Incomederived-$2,583— Margins · derivedGross margin100.0%
Operating margin-1845.0%
Net margin-2137.9%
ended Dec 31, 2013 · filed Apr 15, 2014 · 105 d after period end